Abstract:A high-molecular weight tetrametallic supramolecular complex [(Ln-DTPA-phen)(3)Fe](-) (Ln=Gd, Eu, La) has been obtained upon self-assembly around one iron(II) ion of three 1,10-phenantroline-based molecules substituted in 5'-position with the polyaminocarboxylate diethylenetriamine-N,N,N',N",N"-pentaacetate, DTPA-phen(4-). The ICP-MS measurements indicated that the lanthanide:iron ratio is 3:1. Photoluminescence spectra of [Eu-DTPA-phen](-) and of [(Eu-DTPA-phen)(3)Fe](-) are nearly identical, implying that the first coordination sphere of the lanthanide(III) ion has not been changed upon coordination of phenantroline unit to iron(II) ion. NMRD measurements revealed that at 20 MHz and 310 K the relaxivity of the [(Gd-DTPA-phen)(3)Fe](-) is equal to 9.5 +/- 0.3 s(-1) mM(-1) of Gd (28.5 s(-1) per millimole per liter of complex) which is significantly higher than that for Gd-DTPA (3.9 s(-1) mM(-1)). The pharmacokinetic parameters of [(Gd-DTPA-phen)(3)Fe](-) in rats indicate that the elimination of [(Gd-DTPA-phen)(3)Fe](-) is significantly slower than that of Gd-DTPA and is correlated with a reduced volume of distribution. The low volume of distribution and the longer elimination time (T-e1/2) suggest that the agent is confined to the blood compartment, so it could have an important potential as a blood pool contrast agent. The biodistribution profile of [(Gd-DTPA-phen)(3)Fe](-) 2 h after injection indicates significantly higher concentrations of [(Gd-DTPA-phen)(3)Fe](-) as compared with Gd-DTPA in kidney, liver, lungs, heart and spleen. The images obtained on rats by MR angiography show the enhancement of the abdominal blood vessels. The signal intensity reaches a maximum of 55% at 7 min post-contrast and remains around 25% after 90 min. MRI-histomorphological correlation studies of [Gd-DTPA-phen]- and [(Gd-DTPA-phen)(3)Fe](-) showed that both agents displayed potent contrast enhancement in organs including the liver. The necrosis avidity tests indicated that, in contrast to the [Gd-DTPA-phen]- precursor complex, the supramolecular complex [(Gd-DTPA-phen)(3)Fe](-) exhibits necrosis avidity. Copyright (C) 2006 John Wiley & Sons, Ltd.

Gd(III) complex conjugated ultra-small iron oxide as an enhanced T1-weighted MR imaging contrast agent

Nmr Studies of Gd(Dtpa-Bin) in Human Serum Albumin Solution

Fe3O4 Nanoparticles Functionalized with Polymer Ligand for T-1-Weighted MRI in Vitro and in Vivo

Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast<i>T</i><sub>1</sub>- and<i>T</i><sub>2</sub>-weighted magnetic resonance imaging

Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.

Synthesis of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles with High Relaxivity for T1/T2 Dual-Contrast Magnetic Resonance Imaging

Ultrasmall gadolinium hydrated carbonate nanoparticle: An advanced T 1 MRI contrast agent with large longitudinal relaxivity

In Situ One-Pot Synthesis of Fe 2 O 3 @BSA Core-Shell Nanoparticles as Enhanced T 1 -Weighted Magnetic Resonance Imagine Contrast Agents

2, 3-Dimercaptosuccinic Acid-Modified Iron Oxide Clusters for Magnetic Resonance Imaging

Controlled Synthesis Of Mnfe2o4 Nanoparticles And Gd Complex-Based Nanocomposites As Tunable And Enhanced T-1/T-2-Weighted Mri Contrast Agents

Fe3+@polyDOPA-b-polysarcosine, a T1-Weighted MRI Contrast Agent Via Controlled NTA Polymerization.

A T1/T2 dual functional iron oxide MRI contrast agent with super stability and low hypersensitivity benefited by ultrahigh carboxyl group density

Pharmacokinetic And In Vivo Evaluation Of A Self-Assembled Gadolinium(Iii)-Iron(Ii) Contrast Agent With High Relaxivity

Preparation of Mn2+@PolyDOPA-b-polysarcosine Micelle As MRI Contrast Agent with High Longitudinal Relaxivity

Ultrasmall Ferrite Nanoparticles Synthesized Via Dynamic Simultaneous Thermal Decomposition for High-Performance and Multifunctional T1 Magnetic Resonance Imaging Contrast Agent.

Low-Molecular-Weight Fe(III) Complexes for MRI Contrast Agents

Gadolinium(III) Chelated Conjugated Polymer As a Potential MRI Contrast Agent

Gd-Dots with Strong Ligand-Water Interaction for Ultrasensitive Magnetic Resonance Renography

Biocompatible iron(II)-doped carbon dots as T1-weighted magnetic resonance contrast agents and fluorescence imaging probes

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

Moderate Cooling Coprecipitation for Extremely Small Iron Oxide As a Ph Dependent T1-MRI Contrast Agent.